Johnson & Johnson (JNJ)
202.26
+2.26 (1.13%)
NYSE · Last Trade: Nov 19th, 12:49 PM EST
Detailed Quote
| Previous Close | 200.00 |
|---|---|
| Open | 200.00 |
| Bid | 202.25 |
| Ask | 202.28 |
| Day's Range | 199.38 - 202.27 |
| 52 Week Range | 140.68 - 200.30 |
| Volume | 5,332,596 |
| Market Cap | 531.68B |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | 5.200 (2.57%) |
| 1 Month Average Volume | 8,112,007 |
Chart
About Johnson & Johnson (JNJ)
Johnson & Johnson is a multinational corporation engaged in the development, manufacturing, and marketing of a wide range of healthcare products. The company operates through three primary segments: pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for its commitment to innovation in healthcare, producing a diverse array of products that include prescription medications for various diseases, sophisticated medical devices for surgical procedures, and widely recognized consumer brands for personal care and wellness. With a focus on improving health outcomes, the company aims to address the evolving needs of patients and consumers around the world. Read More
News & Press Releases
Johnson & Johnson had strong Q3 results and reported an important acquisition.
Via The Motley Fool · November 19, 2025
As November 2025 unfolds, the global financial landscape remains under the persistent shadow of elevated inflation and a complex, albeit moderating, interest rate environment. This intricate economic backdrop is casting a pall over global markets, leading to pronounced investor volatility and significantly impacting commodity prices. While some regions show signs
Via MarketMinute · November 19, 2025
Global financial markets are currently navigating a complex psychological landscape characterized by a blend of cautious optimism and palpable apprehension. Investor sentiment, a critical determinant of market direction, is acutely focused on the volatile technology sector, particularly ahead of key earnings reports, and is being shaped by a confluence of
Via MarketMinute · November 19, 2025
As of late 2025, financial markets find themselves mired in a period best described as "choppy"—a landscape characterized by frequent, unpredictable price swings within a relatively confined range, conspicuously lacking a clear, sustained directional trend. This environment has become a significant concern for investors and financial experts alike, as
Via MarketMinute · November 19, 2025
Via MarketBeat · November 19, 2025
As financial markets continue their unpredictable dance, marked by swift corrections and periods of unsettling uncertainty, investors worldwide grapple with the perennial challenge of volatility. In these turbulent times, the siren call of panic selling often grows louder, threatening to derail carefully constructed financial plans. Amidst this backdrop, personal finance
Via MarketMinute · November 19, 2025
Indianapolis, IN – November 19, 2025 – Eli Lilly and Company (NYSE: LLY), the pharmaceutical titan, finds itself at the epicenter of market speculation, firmly placed on "stock split watch" as its share price has soared past the formidable $1,000 mark. This extraordinary ascent, fueled by groundbreaking drug innovations and robust
Via MarketMinute · November 19, 2025
The United States economy is exhibiting increasingly clear signs of a significant slowdown, creating a complex and challenging environment for policymakers at the Federal Reserve. A decelerating labor market, cautious consumer spending, and persistent inflationary pressures are painting a picture of an economy losing steam, while an ongoing federal government
Via MarketMinute · November 18, 2025
The US stock market experienced a significant jolt today, November 18, 2025, as the 'fear index,' or CBOE Volatility Index (VIX), surged dramatically. This sharp rise signals a palpable increase in investor anxiety and a heightened expectation of market turbulence, with major US indices closing lower amidst growing concerns
Via MarketMinute · November 18, 2025
As broader markets grapple with persistent volatility on November 18, 2025, the healthcare sector within the S&P 500 (SPX) finds itself under intense scrutiny. Traditionally viewed as a stalwart defensive play, its performance today is crucial for understanding prevailing market sentiment. Is the sector merely living up to its
Via MarketMinute · November 18, 2025
Amazon (NASDAQ: AMZN) emerged as a significant laggard on the Dow Jones Industrial Average today, November 18, 2025, as its shares experienced a notable decline. This downturn contributed to a broader market slump, particularly impacting the technology sector and signaling a shift in investor sentiment. The tech behemoth's stumble was
Via MarketMinute · November 18, 2025
Bank of America (NYSE: BAC) has recently sounded a significant alarm for the stock market, issuing a "sell signal" that has sent ripples of concern through the financial world. This cautionary indicator, triggered in November 2025, points to dangerously low levels of investor cash balances, suggesting that the market may
Via MarketMinute · November 18, 2025
The U.S. stock market is currently navigating a turbulent period, marked by significant declines across all major indices and a notable four-day losing streak for the S&P 500, its longest such run since August. As of November 18, 2025, a palpable "risk-off" sentiment has gripped investors, fueled by
Via MarketMinute · November 18, 2025
We're back with the second episode of a new series -- 10 Years Later -- where we blast through time to check in on a five-stock sampler from 10 years in the past.
Via The Motley Fool · November 18, 2025
As November 2025 unfolds, global financial markets are caught in a relentless tempest of volatility, characterized by rapid and often dramatic price swings. Investor sentiment has grown increasingly cautious, with a palpable weakening of risk appetite across asset classes. This turbulent environment is forcing a critical reassessment of investment strategies
Via MarketMinute · November 18, 2025
Global financial markets are currently gripped by a palpable "risk-off" sentiment, sending investors scurrying away from speculative assets and towards the perceived safety of traditional havens. This pronounced shift, evident as of November 2025, is contributing to a noticeable downturn across various sectors, signaling a period of heightened caution and
Via MarketMinute · November 18, 2025
New York, NY – November 18, 2025 – Global stock markets experienced a significant plunge today, November 18, 2025, with major U.S. indices hitting multi-week lows as investor sentiment soured dramatically. The tech-heavy Nasdaq Composite led the decline, closing below a key technical indicator for the first time since late April,
Via MarketMinute · November 18, 2025
A cautious start to the week as investors brace for a flood of economic data and Nvidia’s highly anticipated earnings.
Via Chartmill · November 18, 2025
In a period marked by escalating global tensions and economic uncertainty, the US Dollar (Greenback) is exhibiting robust strength, driven by a complex interplay of geopolitical factors and the Federal Reserve's hawkish monetary stance. This formidable appreciation of the dollar is sending significant ripples through global commodity markets, altering pricing
Via MarketMinute · November 17, 2025
2025 has been quite the year for consumer brands, but not in a good way. The industry has underperformed for the past three years and many of the world's largest consumer brand companies are resorting to mergers & acquisitions, asset sales, and spin-offs to rejuvenate their prospects.
Via The Motley Fool · November 17, 2025
The Dow Jones Industrial Average experienced a significant setback today, November 17, 2025, plummeting by approximately 800 points as mounting concerns over the health of the U.S. economy gripped investors. This sharp decline follows closely on the heels of another substantial drop just days earlier, on November 13, 2025,
Via MarketMinute · November 17, 2025
With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.
Via Benzinga · November 17, 2025
Global financial markets are currently gripped by a palpable sense of unease, as elevated valuations, particularly within the high-flying technology and Artificial Intelligence (AI) sectors, spark widespread concern among investors. This apprehension is fueling an accelerating "Great Rotation" of capital, with funds actively migrating out of speculative growth assets and
Via MarketMinute · November 17, 2025
Johnson & Johnson buys Halda for $3.05 billion, adding a prostate cancer candidate as new Tremfya Phase 3b data show sustained benefits through 48 weeks.
Via Benzinga · November 17, 2025